StockData
SpyGlass Pharma, Inc. logo

SpyGlass Pharma, Inc. (SGP) stock

SGPNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$29.68−1.75 (-5.58%)

Close on Nov 18, 2026Market cap $992.74MP/E –Yield –

SpyGlass Pharma free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

For fiscal 2025 it was -$33.49M.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$33.49M–
FY2024Dec 31, 2024-$24.02M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$16.77M–
Q1 FY2026Mar 31, 2026-$14.22M–
Q2 FY2025Jun 30, 2025-$6.38M–
Q1 FY2025Mar 31, 2025-$8.37M–

More SpyGlass Pharma figures

See a number that looks wrong?